Paper35779481
Advances in 3D bioprinting of tissues/organs for regenerative medicine and in-vitro models.
Jain P and 2 others. Biomaterials, 2022. Cited by 144 papers, by iCite.
Cite this record
ConductScience Library. Advances in 3D bioprinting of tissues/organs for regenerative medicine and in-vitro models. Papers, record 35779481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35779481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Advances in 3D bioprinting of tissues/organs for regenerative medicine and in-vitro models.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Cited by95
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 144 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42738888 | Three-Dimensional Bioprinting in Reconstructive Plastic Surgery: A Comprehensive Review. | Cells | 2026 | https://conductscience.org/library/papers/42738888 | PubMed |
| 42518887 | Additive manufacturing for Dentistry: A comprehensive review of techniques and applications. | Prog Mater Sci | 2026 | https://conductscience.org/library/papers/42518887 | PubMed |
| 42415572 | Innovations in the management of urethral stricture disease: emerging and regenerative strategies. | Can J Urol | 2026 | https://conductscience.org/library/papers/42415572 | PubMed |
| 42256080 | From bone replacement to regeneration. A biomaterials started journey. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42256080 | PubMed |
| 42194319 | Additive Manufacturing of Engineered Tissue Constructs: Current Strategies and Future Directions. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42194319 | PubMed |
| 42111769 | Emerging biomodels to understand the pathophysiology of sepsis and evaluate new therapeutic strategies targeting extracellular histones. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42111769 | PubMed |
| 42072200 | Corrosion Behavior and Ion Release of Co-Cr Dental Alloys Fabricated by Casting, CAD/CAM, SLM and DMLS: Influence of Manufacturing Route and Microstructure. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42072200 | PubMed |
| 42015870 | Aptamer-Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/42015870 | PubMed |
| 41975410 | Development and validation of a Novel 3D-printed mold-based silicone model for laparoscopic duodenal stump reinforcement suture simulation training. | BMC Med Educ | 2026 | https://conductscience.org/library/papers/41975410 | PubMed |
| 41899857 | Bio-Printed PCL Tracheal Graft in a Large Animal Model: Reproducible Short-Segment Regeneration and Preliminary Upgraded Long-Segment Reconstruction. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/41899857 | PubMed |
| 41899791 | Simulation-Based Trajectory for Non-Planar Scaffold Printing on Irregular Patches Using Robotic Arm. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/41899791 | PubMed |
| 41892812 | Transformation of the Biological Paradigm in Bone Regeneration: An Integrative Review. | J Dev Biol | 2026 | https://conductscience.org/library/papers/41892812 | PubMed |
| 41892087 | Three-Dimensional Bioprinting and Rose-Inspired Medical Applications. | Biomimetics (Basel) | 2026 | https://conductscience.org/library/papers/41892087 | PubMed |
| 41793088 | The Interaction Between Mitophagy Dysregulation and the Diabetic Bladder Microenvironment. | J Diabetes | 2026 | https://conductscience.org/library/papers/41793088 | PubMed |
| 41767225 | Scaffold-based biomaterials in ovarian tissue engineering. | RSC Adv | 2026 | https://conductscience.org/library/papers/41767225 | PubMed |
| 41645256 | Beyond graphene: the MXene era in bioprinting. | Biomed Eng Online | 2026 | https://conductscience.org/library/papers/41645256 | PubMed |
| 41516221 | 3D Bioprinting Strategies in Autoimmune Disease Models. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516221 | PubMed |
| 41516217 | New Knowledge About Tissue Engineering Under Microgravity Conditions in Space and on Earth. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516217 | PubMed |
| 41419915 | Indirect 3D printing in tissue engineering: expanding materials used for improved scaffold functionality. | Biomed Eng Online | 2025 | https://conductscience.org/library/papers/41419915 | PubMed |
| 41322390 | Genetic engineering frontiers in cell manipulation-based tissue engineering: A comprehensive review. | Bioimpacts | 2025 | https://conductscience.org/library/papers/41322390 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35779481
GET https://conductscience.org/api/papers/v1/35779481/cited_by?page=2